<p>Omada Health, Inc. (NASDAQ:OMDA - 獲取免費報告) 在一月份經歷了顯著的空頭頭寸下降。截至 1 月 15 日，空頭頭寸總計為 1,498,366 股，較 12 月 31 日的 3,282,838 股下降了 54.4%。根據 903,681 股的平均交易量，當前的空頭頭寸比率為 1.7 天。目前，公司 2.6% 的股份被做空。</p>
<h2>Omada Health 股價上漲 1.6%</h2>
<p>NASDAQ OMDA 週四開盤價為 15.65 美元。該公司的 50 日移動平均價格為 16.19 美元，200 日移動平均價格為 19.87 美元。該公司的市值為 9.0629 億美元，市盈率為-62.60。Omada Health 的 12 個月低點為 14.14 美元，12 個月高點為 28.40 美元。</p>
<h2>Omada Health 的內部交易</h2>
<p>在其他消息中，首席執行官 Sean P. Duffy 在 1 月 13 日（星期二）出售了 40,796 股 Omada Health 股票，交易價格為 15.95 美元，總價值為 650,696.20 美元。交易完成後，首席執行官直接持有 126,644 股公司股票，價值約為 2,019,971.80 美元。此次交易使其持股減少了 24.36%。該交易已在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。此外，總裁 Shao Wei-Li 在 12 月 29 日（星期一）出售了 5,618 股公司的股票，交易價格為 16.13 美元，總價值為 90,618.34 美元。交易完成後，總裁直接持有 69,079 股公司股票，價值約為 1,114,244.27 美元。此次交易使其持股減少了 7.52%。該銷售的 SEC 備案提供了更多信息。在過去的 90 天內，內部人士已出售 276,893 股公司股票，價值 4,336,787 美元。</p>
<h2>對 Omada Health 的對沖基金看法</h2>
<p>機構投資者最近對該股票的持倉進行了調整。TD Waterhouse Canada Inc.在第四季度收購了 Omada Health 的新股份，價值約 32,000 美元。Raymond James Financial Inc.在第二季度收購了 Omada Health 的新股份，價值約 32,000 美元。Strs Ohio 在第三季度收購了 Omada Health 的新股份，價值約 38,000 美元。Inlight Wealth Management LLC 在第四季度收購了 Omada Health 的新股份，價值約 45,000 美元。最後，Rakuten Investment Management Inc.在第三季度收購了 Omada Health 的新股份，價值 49,000 美元。</p>
<h2>分析師的升級和降級</h2>
<p>OMDA 已經成為多份研究分析師報告的主題。Evercore ISI 在 11 月 7 日的研究報告中將 Omada Health 的目標價從 27.00 美元上調至 28.00 美元，並給予該股票 “跑贏大盤” 的評級。巴克萊在 1 月 5 日的研究報告中將 Omada Health 的目標價從 29.00 美元下調至 22.00 美元，並對該股票給予 “增持” 評級。Weiss Ratings 在 1 月 22 日的研究報告中重申了對 Omada Health 的 “賣出（d）” 評級。Needham &amp; Company LLC 在 1 月 22 日的報告中重新發布了 “買入” 評級，並設定了 28.00 美元的目標價。最後，BMO Capital Markets 在 11 月 13 日開始對 Omada Health 進行覆蓋，給予 “跑贏大盤” 評級和 27.00 美元的目標價。八位分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat，該公司目前的共識評級為 “適度買入”，共識目標價為 25.10 美元。</p>
<p><strong>查看我們最新的 OMDA 股票報告</strong></p>
<h2>關於 Omada Health</h2>
<p>（獲取免費報告）</p>
<p>Omada Health 是一家數字健康公司，專注於通過個性化、技術驅動的項目來預防和管理慢性疾病。該公司的平台結合了數據分析、行為科學和人類輔導，以支持面臨風險或患有如前糖尿病、2 型糖尿病、高血壓和肌肉骨骼疾病等疾病的個人。參與者通過移動應用程序或網絡門户訪問該項目，在那裏他們可以獲得量身定製的課程、健康指標反饋和持續的虛擬輔導。</p>
<p>除了核心的疾病管理服務外，Omada Health 還擴展了其服務，包括心理健康支持和數字治療以幫助體重管理。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Omada Health</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>1933 年的退款：特朗普的重置可能創造即時財富</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>用這四個簡單步驟 “防止美聯儲影響” 您的銀行賬户</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在 Omada Health 嗎？</h2>
<p>在您考慮 Omada Health 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Omada Health 並不在名單上。</p>
<p>雖然 Omada Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Omada Health, Inc.（納斯達克代碼：OMDA）在 1 月份經歷了空頭頭寸的顯著下降，減少了 54.4%，降至 1,498,366 股。目前的覆蓋天數比率為 1.7 天，空頭賣出股份佔比為 2.6%。該股票開盤價為 15.65 美元，市值為 9.0629 億美元。最近的內部交易包括首席執行官 Sean P. Duffy 出售了 40,796 股。分析師的評級意見不一，普遍評級為 “適度買入”，目標價為 25.10 美元。Omada Health 專注於慢性病的數字健康解決方案</p>

<p>Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,498,366 shares, a decline of 54.4% from the December 31st total of 3,282,838 shares. Based on an average trading volume of 903,681 shares, the short-interest ratio is currently 1.7 days. Currently, 2.6% of the company's shares are sold short. Currently, 2.6% of the company's shares are sold short. Based on an average trading volume of 903,681 shares, the short-interest ratio is currently 1.7 days.</p>
<div class="lb-trans"><p>Omada Health, Inc. (NASDAQ:OMDA - 獲取免費報告) 在一月份經歷了顯著的空頭頭寸下降。截至 1 月 15 日，空頭頭寸總計為 1,498,366 股，較 12 月 31 日的 3,282,838 股下降了 54.4%。根據 903,681 股的平均交易量，當前的空頭頭寸比率為 1.7 天。目前，公司 2.6% 的股份被做空。</p>
</div><h2>Omada Health Trading Up 1.6%</h2>
<div class="lb-trans"><h2>Omada Health 股價上漲 1.6%</h2>
</div><p>NASDAQ OMDA opened at $15.65 on Thursday. The business's 50-day moving average price is $16.19 and its two-hundred day moving average price is $19.87. The firm has a market capitalization of $906.29 million and a PE ratio of -62.60. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40.</p>
<div class="lb-trans"><p>NASDAQ OMDA 週四開盤價為 15.65 美元。該公司的 50 日移動平均價格為 16.19 美元，200 日移動平均價格為 19.87 美元。該公司的市值為 9.0629 億美元，市盈率為-62.60。Omada Health 的 12 個月低點為 14.14 美元，12 個月高點為 28.40 美元。</p>
</div><h2>Insider Transactions at Omada Health</h2>
<div class="lb-trans"><h2>Omada Health 的內部交易</h2>
</div><p>In other news, CEO Sean P. Duffy sold 40,796 shares of Omada Health stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total value of $650,696.20. Following the completion of the sale, the chief executive officer directly owned 126,644 shares in the company, valued at approximately $2,019,971.80. The trade was a 24.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this link. Also, President Wei-Li Shao sold 5,618 shares of the business's stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the transaction, the president directly owned 69,079 shares of the company's stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 276,893 shares of company stock worth $4,336,787.</p>
<div class="lb-trans"><p>在其他消息中，首席執行官 Sean P. Duffy 在 1 月 13 日（星期二）出售了 40,796 股 Omada Health 股票，交易價格為 15.95 美元，總價值為 650,696.20 美元。交易完成後，首席執行官直接持有 126,644 股公司股票，價值約為 2,019,971.80 美元。此次交易使其持股減少了 24.36%。該交易已在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。此外，總裁 Shao Wei-Li 在 12 月 29 日（星期一）出售了 5,618 股公司的股票，交易價格為 16.13 美元，總價值為 90,618.34 美元。交易完成後，總裁直接持有 69,079 股公司股票，價值約為 1,114,244.27 美元。此次交易使其持股減少了 7.52%。該銷售的 SEC 備案提供了更多信息。在過去的 90 天內，內部人士已出售 276,893 股公司股票，價值 4,336,787 美元。</p>
</div><h2>Hedge Funds Weigh In On Omada Health</h2>
<div class="lb-trans"><h2>對 Omada Health 的對沖基金看法</h2>
</div><p>Institutional investors have recently made changes to their positions in the stock. TD Waterhouse Canada Inc. acquired a new stake in Omada Health in the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the 2nd quarter worth about $32,000. Strs Ohio bought a new stake in Omada Health during the 3rd quarter worth approximately $38,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health in the fourth quarter valued at approximately $45,000. Finally, Rakuten Investment Management Inc. purchased a new stake in Omada Health in the 3rd quarter valued at $49,000.</p>
<div class="lb-trans"><p>機構投資者最近對該股票的持倉進行了調整。TD Waterhouse Canada Inc.在第四季度收購了 Omada Health 的新股份，價值約 32,000 美元。Raymond James Financial Inc.在第二季度收購了 Omada Health 的新股份，價值約 32,000 美元。Strs Ohio 在第三季度收購了 Omada Health 的新股份，價值約 38,000 美元。Inlight Wealth Management LLC 在第四季度收購了 Omada Health 的新股份，價值約 45,000 美元。最後，Rakuten Investment Management Inc.在第三季度收購了 Omada Health 的新股份，價值 49,000 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師的升級和降級</h2>
</div><p>OMDA has been the subject of a number of research analyst reports. Evercore ISI upped their price objective on shares of Omada Health from $27.00 to $28.00 and gave the stock an &#34;outperform&#34; rating in a research report on Friday, November 7th. Barclays decreased their target price on shares of Omada Health from $29.00 to $22.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, January 5th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Omada Health in a research note on Thursday, January 22nd. Needham &amp; Company LLC reissued a &#34;buy&#34; rating and set a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. Finally, BMO Capital Markets started coverage on Omada Health in a report on Thursday, November 13th. They issued an &#34;outperform&#34; rating and a $27.00 target price for the company. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $25.10.</p>
<div class="lb-trans"><p>OMDA 已經成為多份研究分析師報告的主題。Evercore ISI 在 11 月 7 日的研究報告中將 Omada Health 的目標價從 27.00 美元上調至 28.00 美元，並給予該股票 “跑贏大盤” 的評級。巴克萊在 1 月 5 日的研究報告中將 Omada Health 的目標價從 29.00 美元下調至 22.00 美元，並對該股票給予 “增持” 評級。Weiss Ratings 在 1 月 22 日的研究報告中重申了對 Omada Health 的 “賣出（d）” 評級。Needham &amp; Company LLC 在 1 月 22 日的報告中重新發布了 “買入” 評級，並設定了 28.00 美元的目標價。最後，BMO Capital Markets 在 11 月 13 日開始對 Omada Health 進行覆蓋，給予 “跑贏大盤” 評級和 27.00 美元的目標價。八位分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat，該公司目前的共識評級為 “適度買入”，共識目標價為 25.10 美元。</p>
</div><p><strong>View Our Latest Stock Report on OMDA</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 OMDA 股票報告</strong></p>
</div><h2>About Omada Health</h2>
<div class="lb-trans"><h2>關於 Omada Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.</p>
<div class="lb-trans"><p>Omada Health 是一家數字健康公司，專注於通過個性化、技術驅動的項目來預防和管理慢性疾病。該公司的平台結合了數據分析、行為科學和人類輔導，以支持面臨風險或患有如前糖尿病、2 型糖尿病、高血壓和肌肉骨骼疾病等疾病的個人。參與者通過移動應用程序或網絡門户訪問該項目，在那裏他們可以獲得量身定製的課程、健康指標反饋和持續的虛擬輔導。</p>
</div><p>In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.</p>
<div class="lb-trans"><p>除了核心的疾病管理服務外，Omada Health 還擴展了其服務，包括心理健康支持和數字治療以幫助體重管理。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Omada Health</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>1933 年的退款：特朗普的重置可能創造即時財富</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>用這四個簡單步驟 “防止美聯儲影響” 您的銀行賬户</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在 Omada Health 嗎？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Omada Health 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Omada Health 並不在名單上。</p>
</div><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Omada Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Omada Health, Inc. (NASDAQ:OMDA) 的空頭頭寸在一月份減少了 54.4%